OSN New York Meeting

Program

8:00 am – 9:00 am

Industry Expert Theater Breakfast: So Your Patients Don’t Have to...**

  • Presented by Ocular Therapeutix, Inc.
    Alice T. Epitropoulos, MD, FACS; John A. Hovanesian, MD, FACS
9:00 am – 9:15 am

Exhibit Hall Break

9:15 am – 9:20 am

Opening Remarks
Richard L. Lindstrom, MD

9:20 am – 10:25 am

What’s New in Cataract Surgery
Moderator: Elizabeth Yeu, MD

Introduction and Pretest

Update on Drug Delivery for the Cataract Surgeon
Eric D. Donnenfeld, MD

How Cataract Planning Software Have Improved the Cataract Surgery Process
Brandon D. Ayres, MD

The Latest and Next-Generation Presbyopia IOL Technology
Marjan Farid, MD

Utilizing LAL for Precise Monovision and Astigmatism Correction
Deborah G. Ristvedt, DO

Expanding My Intraoperative Device and Toolbox
Nicole R. Fram, MD

Novel IOL Extraction Device and Technique
William F. Wiley, MD

Cost Containment and Logistical Management for the Expanding Scope of Cataract Surgery “Add-ons”
Kendall E. Donaldson, MD, MS

Discussion and Q&A/Posttest

10:25 am – 10:45 am

Exhibit Hall Break

10:45 am – 11:50 am

Complex Cases and Complications Management in Cataract Surgery
Moderator: John P. Berdahl, MD

Introduction and Pretest

Overcoming Challenges in Hypermature, Congenital & Dangling Cataract Cases
Ashvin Agarwal, MS

Challenges with Anesthesia and Akinesia
Uday Devgan, MD

IOL Exchange After Capsulotomy
William F. Wiley, MD

Glaucoma Cataracts: Hijinks and Hyphemas
Nathan M. Radcliffe, MD

Post-op Management of the Phaco MIGS Eye
Sarah H. Van Tassel, MD

Repair of Dialysis Caused by an Implantable Microstent
Brandon D. Ayres, MD

Femotsecond Laser for White Cataract Surgery
Preeya Gupta, MD

Intravitreal Injections: Beware
Thomas A. Oetting, MD

Panel Discussion, Q&A and Posttest

11:50 am – 12:55 pm

Medical & Surgical Management of Corneal Conditions
Moderator: Terry Kim, MD
Panelists: Brandon D. Ayres, MD; Kendall E. Donaldson, MD, MS; Nicole R. Fram, MD; Himani Goyal, MD; Parag A. Majmudar, MD; Karolinne M. Rocha, MD, PhD; Mitchell P. Weikert, MD, MS

12:55 pm – 1:10 pm

Break

1:10 pm – 2:10 pm

Industry Expert Theater Lunch: Navigating Dry Eye Disease: An Audience-Activated Adventure**

  • Presented by Novartis Pharmaceuticals Corporation
    Jay Mattheis, MD; Whitney Hauser, OD, FAAO
2:10 pm – 2:20 pm

From AI to 5G: How Tech is Changing Ophthalmology and Low Vision
Presenter: Calvin W. Roberts, MD

2:20 pm – 2:30 pm

Waring Medal Presentation*

2:30 pm – 3:40 pm

Corneal-based Refractive Surgery
Moderator: William B. Trattler, MD
Panelists: Ashvin Agarwal, MS; Kendall E. Donaldson, MD, MS; Eric D. Donnenfeld, MD; Mitchell A. Jackson, MD; Parag A. Majmudar, MD; Karolinne M. Rocha, MD, PhD; Priyanka Sood, MD

Introduction and Pretest

Refractive Surgery Innovations in 2022 and Beyond: What to Look Out for Next
George O. Waring IV, MD, FACS

Panel Discussion: Innovations

Arriving Soon: Drops for Presbyopia and their Impact on Refractive Surgery
Jennifer M. Loh, MD

Panel Discussion: Presbyopia Correcting Eye Drops

Surgical Videos for Optimizing ICL Insertion and Removal
William F. Wiley, MD

Surgical Videos for SMILE
Kathryn M. Hatch, MD

Surgical Videos for PRK
Marguerite B. McDonald, MD, FACS

Surgical Videos for LASIK
Mark A. Kontos, MD

Panel Discussion: Challenging Cases in Refractive Surgery
William B. Trattler, MD

Posttest

3:40 pm – 3:55 pm

Exhibit Hall Break

3:55 pm – 5:20 pm

OSN’s Disruptive Innovations Symposium**
The Latest Advances in Diagnostics, Drug Delivery and Surgical Devices

5:20 pm – 6:00 pm

Meet the Faculty Reception*

*These sessions are not approved for AMA PRA Category 1 Credit(s)™.
**These sessions are not approved for AMA PRA Category 1 Credit(s)™ and are neither provided by nor endorsed by OSN New York 2021 or its accredited provider.

8:00 am – 9:00 am

Breakfast Program: The Frustration Factor: Presbyopia in the Modern Age**

  • This promotional educational event is presented by Allergan, an AbbVie company.
    George O. Waring IV MD, FACS; Karolinne Maia Rocha, MD, PhD; Christopher E. Starr, MD
9:00 am – 9:15 am

Exhibit Hall Break

9:15 am – 9:20 am

Opening Remarks
Richard L. Lindstrom, MD

9:20 am – 10:30 am

Astigmatism Management: Toric IOLs and Limbal Relaxing Incisions
Moderator: John A. Hovanesian, MD, FACS

Introduction and Pretest

New Digital Tools to Drive Accuracy and Adoption in Refractive Cataract Surgery
John A. Hovanesian, MD, FACS

Immunomodulators for Better Refractive Outcomes in Dry Eye Patients
Alice T. Epitropoulos, MD

What to Do When the Astigmatic Axis varies with Different Pre-op Biometers
Uday Devgan, MD

Toric IOLs: What’s Out There?
Darrell E. White, MD

Astigmatism Enhancements After Cataract Surgery
John P. Berdahl, MD

Intraoperative Digital Marking: Do I Really Need This?
Nicole R. Fram, MD

Pinhole Pupilloplasty
Ashvin Agarwal, MS

Suture Fixation of Toric IOLs
Brandon D. Ayres, MD

Discussion and Posttest

10:30 am – 10:50 am

Exhibit Hall Break

10:50 am – 11:55 am

Retina
Moderator: Andrew A. Moshfeghi, MD, MBA

Introduction and Pretest

What’s New in the Treatment of Age-related Macular Degeneration?
Andrew A. Moshfeghi, MD, MBA

Pearls for the Anterior Segment Surgeon from the Retina Surgeon’s Perspective
Jorge A. Fortun, MD

Mathematical Concepts in Understanding Retinal Diseases
Darius M. Moshfeghi, MD

11:55 am – 12:00 pm

Break

12:00 pm – 1:00 pm

CME Lunch Seminar: Medical Retina Update: Applying New Data to Practice
Supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

1:00 pm – 2:10 pm

IOLs and Lens-based Refractive Surgery
Moderator: Nicole R. Fram, MD

Introduction and Pretest
Nicole R. Fram, MD

Pearls for Selecting (or not selecting) the Best Presbyopia-correcting IOL for Your Patient
William B. Trattler, MD

Should I Look at Higher Order Aberrations and Why Does it Matter?
Karolinne M. Rocha, MD, PhD

Dysfunctional Lens Syndrome and ICLs
George O. Waring IV, MD, FACS

How do I Implement a New Technology Before I Really Know How It Works?
Mitchell P. Weikert, MD, MS

My Patient is Unhappy in the First Eye: What Should I Do?
Nicole R. Fram, MD

How to Handle Capsular Issues When a Premium IOL is Planned?
Uday Devgan, MD

Discussion, Q&A and Posttest

2:10 pm – 2:30 pm

Exhibit Hall Break

2:30 pm – 3:00 pm

Neuro-Opthalomogy Update
Five Neuro-opthalmologic Diagnoses You Cannot Afford to Miss
Andrew G. Lee, MD

3:00 pm – 4:30 pm

Glaucoma
Moderator: Thomas W. Samuelson, MD

Introduction and Pretest

Case One: The Newly Diagnosed Glaucoma Patient
Thomas W. Samuelson, MD

The Case for SLT
Nathan M. Radcliffe, MD

The Case for Depot Drug Delivery
Sarah H. Van Tassel, MD

The Case for Eyedrop Therapy
Audience Volunteer & Panel Discussion

Panel Discussion

Case Two: Cataract and Mild Glaucoma
Thomas W. Samuelson, MD

The Case for Phaco plus Canal Stent Device
Sarah H. Van Tassel, MD

The Case for Phaco plus Segmental Goniotomy
Valerie Trubnik, MD, FACS

The Case for Phaco plus Combined Canal Dialation/Goniotomy
Manjool Shah, MD

Panel Discussion

Case Three: Cataract and Moderate to Severe Glaucoma
Thomas W. Samuelson, MD

The Case for Phaco plus Combined MIGS
Nathan M. Radcliffe, MD

The Case for Phaco plus Gel Stent
Valerie Trubnik, MD, FACS

The Case for Phaco plus Trab or Tube
Manjool Shah, MD

Panel Discussion and Postest

Glacuoma Hot Topics
Moderator: Thomas W. Samuelson, MD
Panelists: Nathan M. Radcliffe, MD; Manjool Shah, MD; Valerie Trubnik, MD, FACS; Sarah H. Van Tas-sel, MD

*These sessions are not approved for AMA PRA Category 1 Credit(s)™.
**These sessions are not approved for AMA PRA Category 1 Credit(s)™ and are neither provided by nor endorsed by OSN New York 2021 or its accredited provider.

8:00 am – 9:00 am

CME Breakfast Seminar: Mitigating Thyroid Eye Disease through Prompt Diagnosis and Treatment

  • Supported by an educational grant from Horizon Therapeutics USA, Inc.
    Moderator: Gary J. Lelli Jr., MD
    Faculty: Prem S. Subramanian, MD, PhD

Introduction and Pre-test
Gary Lelli Jr., MD

Thyroid Eye Disease: Challenges in Diagnosis
Prem S. Subramanian, MD, PhD

  • Etiology, pathogenesis, relevant risks and factors
  • Difficult diagnosis due to heterogeneous signs and symptoms
  • Use of imaging for detection

Case Presentation: Differential Diagnosis
Prem S. Subramanian, MD, PhD

Incorporating Best Practices for the Treatment of Thyroid Eye Disease
Gary Lelli Jr., MD

  • Management during active phase versus stable
  • Conventional use of steroids – benefits and limitations
  • Use and safety considerations of newly approved biologic, teprotumumab
  • Multidisciplinary care strategies

Case Presentation: Treatment of Thyroid Eye Disease
Gary Lelli Jr., MD

Post-test and Q&A

9:00 am – 9:05 am

Opening Remarks

  • Richard L. Lindstrom, MD
9:05 am – 10:05 am

Practice Management
Moderator: Candace S. Simerson, FASOA, COE, CMPE

Ophthalmology Trends and Private Equity Penetration
Richard C. Edlow, OD

Coding Update
Mary Pat Johnson, COMT, CPC, COE, CPMA

10:05 am – 10:20 am

Exhibit Hall Break

10:20 am – 11:25 am

Corneal Health Roundtables: NSAIDs and Anti-infectives
Moderator: Eric D. Donnenfeld, MD
Panelists: Nicole R. Fram, MD; P. Dee Stephenson, MD, FACS, ABES, FSEE; William B. Trattler, MD; John A. Hovanesian, MD, FACS; Terry Kim, MD

11:25 am – 12:25 pm

CME Seminar: Navigating Emerging Approaches for the Treatment of nAMD and DME

  • Supported by an educational grant from Genentech, a member of the Roche Group
    Moderator: Sophie J. Bakri, MD
    Faculty: Dilsher S. Dhoot, MD

Introduction and Pre-test
Sophie J. Bakri, MD

MOAs on the Move: Emerging Action in nAMD and DME Treatment
Dilsher S. Dhoot, MD

Review of current evidence pertaining to treatment burden and dosing regimens in nAMD, and DME.

Discussion of new and emerging therapeutics that offer extended duration with unique mechanisms and extended duration in nAMD and DME:

  • Faricimab – bispecific for VEGF and Ang2, ability to maintain vascular stability – use inn AMD, DME — AVENUE, STAIRWAY, BOULEVARD, TENAYA, LUCERNE, RHINE, YOSEMITE
  • KSI-301 and GB-102

Advances in Delivery for the Treatment of nAMD and DME
Sophie J. Bakri, MD

  • Systems that deliver medication for extended periods of time – Refillable, rigid port delivery system (PDS), gene therapy, miniature pumps, bioerodible implants, suprachoroidal surgery
  • Status of gene therapy – ADVM-022, RGX-314
  • PDS with ranibizumab: Surgical techniques required, laser ablation, tips and tricks for surgery, avoiding complications, in-clinic refill

Updates on LADDER, ARCHWAY, Pagoda, PORTAL (extension study), and Pavilion

Post-test and Q&A

12:25 pm – 1:25 pm

Corneal Health Roundtables: Dry Eye, Allergy and Anti-infectives
Moderator: Eric D. Donnenfeld, MD
Panelists: Kenneth R. Kenyon, MD; Henry “Hank” D. Perry, MD; Darrell E. White, MD; Cynthia Matossian, MD, FACS; Marguerite B. McDonald, MD, FACS; Elizabeth Yeu, MD

1:25 pm

Closing Remarks and Lunch To Go

*These sessions are not approved for AMA PRA Category 1 Credit(s)™.
**These sessions are not approved for AMA PRA Category 1 Credit(s)™ and are neither provided by nor endorsed by OSN New York 2021 or its accredited provider.